↧
FDA Approves Merck’s VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C...
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)– Merck (NYSE:MRK) (known as MSD outside the United States and Canada) announced today that the U.S. Food and Drug Administration (FDA) has approved VICTRELIS”...
View ArticleNature Supplement
Nature Supplement Hepatitis C Vol. 474 No. 7350_supp S1-S48 In this Supplement Infecting around 120 million people worldwide, hepatitis C virus (HCV) is more common than HIV yet it is a neglected...
View ArticleNEW VIDEO::: Raising Awareness for Hepatitis : PANEL 2
Raising Awareness for Hepatitis : PANEL 2
View Article
More Pages to Explore .....